Modeling Familial Clustered Breast Cancer Using Published Data

Cancer Epidemiology Biomarkers and Prevention

Volumn 12, Issue 12, 2003, Pages 1479-1485

  Jonker, M A ^a   Jacobi, C E ^a   Hoogendoorn, W E ^a   Nagelkerke, N J D ^a   De Bock, Geertruida H ^a   Van Houwelingen, Johannes C ^b  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN; GENE PRODUCT; PROTEIN BRCAU; UNCLASSIFIED DRUG;

ARTICLE; BREAST CANCER; CANCER INCIDENCE; CANCER RISK; DOMINANT GENE; FAMILIAL CANCER; FAMILY HISTORY; GENETIC MODEL; GENETIC SUSCEPTIBILITY; ONCOGENE; PRIORITY JOURNAL; RECESSIVE GENE; RISK ASSESSMENT;

ADULT; AGE DISTRIBUTION; AGED; BREAST NEOPLASMS; CLUSTER ANALYSIS; FEMALE; GENES, BRCA1; GENES, BRCA2; GENETIC PREDISPOSITION TO DISEASE; GENETIC SCREENING; HETEROZYGOTE; HUMANS; INCIDENCE; MIDDLE AGED; MODELS, GENETIC; NETHERLANDS; PEDIGREE; PROGNOSIS; RISK ASSESSMENT;

EID: 0347993722     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Collaborative Group on Hormonal Factors in Breast Cancer. Familial breast cancer: collaborative reanalysis of individual data from 52 epidemiological studies including 58 209 women with breast cancer and 101 986 women without disease. Lancet, 358: 1389-1399, 2001.
2. Pharoah, P. D., Lipscombe, J. M., Redman, K. L., Day, N. E., Easton, D. F., and Ponder, B. A. Familial predisposition to breast cancer in a British population: implications for prevention. Eur. J. Cancer, 36: 773-779. 2000.
3. Pharoah, P. D., Day, N. E., Duffy, S., Easton, D. F., and Ponder, B. A. Family history and the risk of breast cancer: a systematic review and meta-analysis. Int. J. Cancer, 71: 800-809, 1997.
4. Claus, E. B., Risch, N., and Thompson, W. D. Genetic Analysis of breast cancer in the cancer and steroid hormone study. Am. J. Hum. Genet., 48: 232-242, 1991.
5. Miki, Y., Swensen, J., Shattuck-Eidens, D., Futieal, P. A., Harshman. K., Tavtigian, S., Liu, Q., Cochran, C., Bennett, L. M., Diag, W., Bell, R., Rosenthal, J., Hussey, C., Tran, T., McClure, M., Frye, C., Hattier, T., Phelps, R., Haugenstrano, A., Katcher, H., Yakumo, K., Gholami, Z., Shaffer, D., Stone, S., Bayer, S., Wray, C., Bogden, R., Dayananth, P., Ward, J., Tonin, P., Narod, S., Bristow, P. K., Norris, F. H., Helvering, L., Morrison, P., Rosteck, P., Lai, M., Barrett, J. C., Lewis, C., Neuhausen, S., Cannonalbright, L., Goldgar, D., Wiseman, R., Kamb, A., and Skolnick, M. H. A, strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science (Wash. DC), 266: 66-71, 1994.
6. Wooster, R., Bignell, G., Lancaster, J., Swift, S., Seal, S., Mangion, J., Collins, N., Gregory, S., Gumbs, C., and Micklem, G. Identification of the breast cancer susceptibility gene BRCA2. Nature (Lond.), 378: 789-791, 1995.
7. Ford, D., Easton, D. F., and Peto, J. Estimation of the frequency of BRCA1 and its contribution to breast and ovarian cancer incidence. Am. J. Hum. Genet., 57: 1457-1462, 1995.
8. Peto, J., Collins, N., Barfoot, R., Seal, S., Warren, W., Rahman, N., Easton, D. F., Evans, C., Deacon, J., and Stratton, M. R. Prevalence of BRCA1 and BRCA2 gene mutations in patients with early onset breast cancer. J. Natl. Cancer Inst., 91: 943-949, 1999.
9. Ford, D., Easton, D. F., Stratton, M., Narod, S. Goldgar, D., Devilee, P., Bishop, D. T., Weber, B., Lenoir, G., Chang-Claude, J., Sobol, H., Teare, M. D., Struewing, J., Arason, A., Scherneck, S., Peto, J., Rebeck, T. R., Tonin, P., Neuhausen, S., Barkardottir, R., Eyfjord, J., Lynch, H., Ponder, B. A., Cayther, S. A., and Zelada-Hedman, M. Genetic heterogeneity and penetrancy analysis of the BRCA1 and the BRCA2 genes in breast cancer families. Am. J. Hum. Genet., 62: 676-689, 1998.
10. Easton, D. F., Ford, D., Bishop, D. T., and the Breast Cancer Linkage Consortium. Breast and ovarian cancer incidence in BRCA1-mutation carriers. Am. J. Hum. Genet., 56. 265-271, 1995.
11. Parmigiani, G., Berry, D. A., and Aguilar, O. Determining carrier probabilities for breast cancer susceptibility genes BRCA1 and BRCA2. Am. J. Hum. Genet., 62: 145-158, 1998.
12. Berry, D. A., Iversen, E. S., Jr., Gudbjartsson, D. F., Hiller, E. H., Garber, J. E., Peshkin, B. N., Lerman, C., Watson, P., Lynch, H. T., Hilsenbeck, S. G., Rubinstein, W. S., Hughes, K. S., and Parmigiani, G. BRCAPRO validation, sensitivity of genetic testing of BRCA1/BRCA2, and prevalence of other breast cancer susceptibility genes. J. Clin. Oncol., 20: 2701-2712, 2002.
13. Nathanson, K. L., Wooster, R., and Weber, B. L. Breast cancer genetics: what we know and what we need. Nat. Med., 7: 552-556, 2001.
14. Hopper, J. L., and Carlin, J. B. Familial aggregation of a disease consequent upon correlation between relatives in a risk factor measured on a continuous scale. Am. J. Epidemiol., 136: 1138-1147. 1992.
15. Antoniou, A. C., Pharoah, P. D. P., McMullan, G., Day, N. E., Ponder, B. A. J., and Easton, D. F. Evidence for further breast cancer susceptibility genes in addition to BRCA1 and BRCA2 in a population-based study. Genet. Epidemiol., 21: 1-18, 2001.
16. Antoniou, A. C., Pharoah, P. D. P., McMullan, G., Day, N. E., Straton, M. R., Peto, J., Ponder, B. J., and Easton, D. F. A. comprehensive model for familial breast cancer incorporating BRCA1, BRCA2 and other genes. Br. J. Cancer, 86: 76-83, 2002.
17. Cui, J., Antoniou, A. C., Dite, G. S., Southey, M. C., Venter, D. J., Easton, D. F., Giles, G. G., McCredie, M. R. E., and Hopper, J. L. After BRCA1 and BRCA2 - what next? multifactorial segregation analyses of three-generation, population-based australian families affected by female breast cancer. Am. J. Hum. Genet., 68: 420-431, 2001.
18. Visser, O., Coebergh, J. M. W., and Schouten, L. J. Incidence of Cancer in the Netherlands 1989. Fourth Report of the Netherlands Cancer Registry. Utrecht, 1995.
19. Hoskins, K. F., Stopfer, J. E., Calzone, K. A., Merajver, S. D., Rebbeck, T. R., Garber, J. E., and Weber, B. L. Assessment and counselling for women with a family history of breast cancer. J. Am. Med. Assoc., 273: 577-585, 1995.
20. Antoniou, A., Pharoah, P. D. P., Narod, S., Risch, H. A., Eyfjord, J. E., Hopper, J. L., Loman, N., Olsson, H., Johannsson, O., Borg, A., Pasini, B., Radice, P., Manoukian, S., Eccles, D. M., Tang, N., Olah, E., Anton-Culver, H., Wamer, E., Lubinski, J., Gronwald, J., Gorski, B., Tulinius, H., Thorlacius, S., Eerola, H., Nevanlinna, H., Syrjekoski, K., Kallioniemi, O. P., Thompson, D., Evans, C., Peto, J., Lalloo, F., Evans, D. G., and Easton, D. F. Average risks of breast and ovarian cancer associated with BRCA1 and BRCA2 mutations detected in case series unselected for family history: a combined analysis of 22 studies. Am. J. Hum. Genet., 72: 1117-1130, 2003.
21. Claus, E. B., Risch, N., and Thompson, W. D. Autosomal dominant inheritance of early-onset breast cancer: implications for risk prediction. Cancer (Phila.), 81: 1879-1886, 1994.
22. Freimer, N. B., Heutink, P., and Wijmenga, C. Obituary: Lodewijk A. Sandkuijl (July 31, 1953 - December 4, 2002). Am. J. Human Genet., 72: 781-784, 2003.